Advertisement

Current Diabetes Reports

, Volume 13, Issue 1, pp 130–137 | Cite as

Adult Hyperglycemic Crisis: A Review and Perspective

  • Devin W. Steenkamp
  • Sara M. Alexanian
  • Marie E. McDonnellEmail author
Hospital Management of Diabetes (G Umpierrez, Section Editor)

Abstract

Hyperglycemic crisis, which includes Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State, is a common diagnosis in high acuity hospital units and admission rates continue to increase despite preventive strategies. While diabetic ketoacidosis remains a common cause of death in children and adolescents with type 1 diabetes, in adults reported mortality is variable and depends on the severity of metabolic derangement and the presence of other acute and chronic conditions. Hyperosmolar hyperglycemic state, and the overlap syndrome of hyperosmolar ketoacidosis, have a higher overall mortality though outcomes are improving. We discuss the diagnosis, epidemiology, and management strategies with particular reference to commonly encountered pitfalls in care and provide an updated perspective on the shifts in the epidemiology and novel management strategies for these important disorders.

Keywords

Hyperglycemic crisis Diabetic ketoacidosis Hyperglycemic hyperosmolar state Adults 

Notes

Disclosure

No potential conflicts of interest relevant to this article were reported.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Walker M, Marshall SM, Alberti KG. Clinical aspects of diabetic ketoacidosis. Diabetes Metab Rev. 1989;5:651–63.PubMedCrossRefGoogle Scholar
  2. 2.
    • Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32:1335–43. Consensus statement from the American Diabetes Association which provides a comprehensive overview of the topic.PubMedCrossRefGoogle Scholar
  3. 3.
    Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008;93:1541–52.PubMedCrossRefGoogle Scholar
  4. 4.
    Umpierrez GE, Khajavi M, Kitabchi AE. Review: diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Am J Med Sci. 1996;311:225–33.PubMedCrossRefGoogle Scholar
  5. 5.
    Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–82.PubMedCrossRefGoogle Scholar
  6. 6.
    Control CfD. Avialable at: http://www.cdc.gov/diabetes/statistics/dkafirst/fig 7.htm. x: x; 2012 [cited 2012]. Accessed 1 Aug 2012.
  7. 7.
    Gordon EE, Kabadi UM. The hyperglycemic hyperosmolar syndrome. Am J Med Sci. 1976;271:252–68.PubMedCrossRefGoogle Scholar
  8. 8.
    Wachtel TJ, Tetu-Mouradjian LM, Goldman DL, Ellis SE, O'Sullivan PS. Hyperosmolarity and acidosis in diabetes mellitus: a three-year experience in Rhode Island. J Gen Intern Med. 1991;6:495–502.PubMedCrossRefGoogle Scholar
  9. 9.
    Faich GA, Fishbein HA, Ellis SE. The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol. 1983;117:551–8.PubMedGoogle Scholar
  10. 10.
    Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Lee W, et al. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diabetes. 2009;10 Suppl 12:118–33.PubMedCrossRefGoogle Scholar
  11. 11.
    Basu A, Close CF, Jenkins D, Krentz AJ, Nattrass M, Wright AD. Persisting mortality in diabetic ketoacidosis. Diabet Med. 1993;10:282–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Tillman CR. Hypokalemic hypoventilation complicating severe diabetic ketoacidosis. South Med J. 1980;73:231–3.PubMedCrossRefGoogle Scholar
  13. 13.
    Arora S, Cheng D, Wyler B, Menchine M. Prevalence of hypokalemia in ED patients with diabetic ketoacidosis. Am J Emerg Med. 2012;30:481–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Umpierrez GaS D. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. In: Fonseca V, editor. Clinical diabetes: Elsevier; 2006.Google Scholar
  15. 15.
    Barski L, Nevzorov R, Rabaev E, Jotkowitz A, Harman-Boehm I, Zektser M, et al. Diabetic ketoacidosis: clinical characteristics, precipitating factors, and outcomes of care. IMAJ. 2012;14:299–303.PubMedGoogle Scholar
  16. 16.
    Chen HF, Wang CY, Lee HY, See TT, Chen MH, Jiang JY, et al. Short-term case fatality rate and associated factors among inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 15-year period. Intern Med. 2010;49:729–37.PubMedCrossRefGoogle Scholar
  17. 17.
    de Vries L, Oren L, Lebenthal Y, Shalitin S, Lazar L, Phillip M. Decrease in frequency of ketoacidosis at diabetes onset over the past two decades - perspectives of a paediatric tertiary care centre. Diabet Med. 2012;29(8):e170–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Ekpebegh CO, Longo-Mbenza B, Akinrinmade A, Blanco-Blanco E, Badri M, Levitt NS. Hyperglycaemic crisis in the Eastern Cape province of South Africa: high mortality and association of hyperosmolar ketoacidosis with a new diagnosis of diabetes. Suid-Afrikaanse Tydskrif Vir Geneeskd. 2010;100:822–6.Google Scholar
  19. 19.
    Negrato CA, Cobas RA, Gomes MB; Brazilian Type 1 Diabetes Study Group. Temporal changes in the diagnosis of type 1 diabetes by diabetic ketoacidosis in Brazil: a nationwide survey. Diabet Med. 2012; 29(9):1142–7.Google Scholar
  20. 20.
    Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes. 2004;53:645–53.PubMedCrossRefGoogle Scholar
  21. 21.
    Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med. 1999;159:2317–22.PubMedCrossRefGoogle Scholar
  22. 22.
    • Randall L, Begovic J, Hudson M, Smiley D, Peng L, Pitre N, et al. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care. 2011;34:1891–6. This article highlights the non biological precipitants and comorbidities that are common to recurrant DKA admissions and the challenges that accompany this issue.PubMedCrossRefGoogle Scholar
  23. 23.
    Rewers A. Current concepts and controversies in prevention and treatment of diabetic ketoacidosis in children. Curr Diab Rep. 2012;12(5):524–32.Google Scholar
  24. 24.
    Fritsch M, Rosenbauer J, Schober E, Neu A, Placzek K, Holl RW, et al. Predictors of diabetic ketoacidosis in children and adolescents with type 1 diabetes. Experience from a large multicentre database. Pediatr Diabetes. 2011;12(4 Pt 1):307–12.PubMedCrossRefGoogle Scholar
  25. 25.
    Weinert LS, Scheffel RS, Severo MD, Cioffi AP, Telo GH, Boschi A, et al. Precipitating factors of diabetic ketoacidosis at a public hospital in a middle-income country. Diabetes Res Clin Pract. 2012;96:29–34.PubMedCrossRefGoogle Scholar
  26. 26.
    MacIsaac RJ, Lee LY, McNeil KJ, Tsalamandris C, Jerums G. Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies. Intern Med J. 2002;32:379–85.PubMedCrossRefGoogle Scholar
  27. 27.
    Isotani H, Asaka S, Kameoka K, Furukawa K. Hyperglycemic hyperosmolar syndrome associated with severe ketosis in Japanese woman. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et Metabolisme. 1997;29:360–1.Google Scholar
  28. 28.
    Bhowmick SK, Levens KL, Rettig KR. Hyperosmolar hyperglycemic crisis: an acute life-threatening event in children and adolescents with type 2 diabetes mellitus. Endocr Pract. 2005;11:23–9.PubMedGoogle Scholar
  29. 29.
    Nyenwe EA, Razavi LN, Kitabchi AE, Khan AN, Wan JY. Acidosis: the prime determinant of depressed sensorium in diabetic ketoacidosis. Diabetes Care. 2010;33:1837–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Faigel DO, Metz DC. Prevalence, etiology, and prognostic significance of upper gastrointestinal hemorrhage in diabetic ketoacidosis. Dig Dis Sci. 1996;41:1–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Byard RW, Zhou C. Erosive gastritis, Armanni-Ebstein phenomenon and diabetic ketoacidosis. Forensic Sci Med Pathol. 2010;6(4):304–6. Epub 2010/07/16.PubMedCrossRefGoogle Scholar
  32. 32.
    Rewers A. Current concepts and controversies in prevention and treatment of diabetic ketoacidosis in children. Curr Diabetes Rep. 2012;12:524–32.CrossRefGoogle Scholar
  33. 33.
    Nyenwe EA, Loganathan RS, Blum S, Ezuteh DO, Erani DM, Wan JY, et al. Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital. Endocr Pract. 2007;13:22–9.PubMedGoogle Scholar
  34. 34.
    Warner EA, Greene GS, Buchsbaum MS, Cooper DS, Robinson BE. Diabetic ketoacidosis associated with cocaine use. Arch Intern Med. 1998;158:1799–802.PubMedCrossRefGoogle Scholar
  35. 35.
    Rehman HU. A woman with ketoacidosis but not diabetes. BMJ. 2012;344:e1535.PubMedCrossRefGoogle Scholar
  36. 36.
    Franke B, Carr D, Hatem MH. A case of euglycaemic diabetic ketoacidosis in pregnancy. Diabet Med. 2001;18:858–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Burge MR, Hardy KJ, Schade DS. Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency. J Clin Endocrinol Metab. 1993;76:1192–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Glaser N, Kuppermann N. DKA-related cerebral edema and intravenous fluid therapy: potential pitfalls of uncontrolled retrospective studies. J Pediatr. 2008;152:145. author reply 7–9.PubMedGoogle Scholar
  39. 39.
    Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, et al. Efficacy of subcutaneous insulin lispro vs continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004;117:291–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care. 2004;27:1873–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32:1119–31.PubMedCrossRefGoogle Scholar
  42. 42.
    Umpierrez GE, Jones S, Smiley D, Mulligan P, Keyler T, Temponi A, et al. Insulin analogs vs human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes Care. 2009;32:1164–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Kitabchi AE, Nyenwe EA. Hyperglycemic crises in diabetes mellitus: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin North Am. 2006;35:725–51. viii.PubMedCrossRefGoogle Scholar
  44. 44.
    Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553–91.PubMedCrossRefGoogle Scholar
  45. 45.
    Aggarwal A, Rawn JD, Pendergrass ML, Garg RK. Long-acting subcutaneously administered insulin for glycemic control immediately after cardiac surgery. Endocr Pract. 2011;17:558–62.PubMedCrossRefGoogle Scholar
  46. 46.
    Avanzini F, Marelli G, Donzelli W, Busi G, Carbone S, Bellato L, et al. Transition from intravenous to subcutaneous insulin: effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome. Diabetes Care. 2011;34:1445–50.PubMedCrossRefGoogle Scholar
  47. 47.
    • Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, et al. Subcutaneous Administration of Glargine to Diabetic Patients Receiving Insulin Infusion Prevents Rebound Hyperglycemia. J Clin Endocrinol Metab. 2012;97(9):3132–7. This study brings to light a potential new approach to transition from intravenous to subcutaneous insulin therapy to ameliorate the risk of rebound hyperglycemia. Google Scholar
  48. 48.
    Rubin DJ, Rybin D, Doros G, McDonnell ME. Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes. Diabetes Care. 2011;34:1723–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE. Hyperglycemic crises in urban blacks. Arch Intern Med. 1997;157:669–75.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Devin W. Steenkamp
    • 1
  • Sara M. Alexanian
    • 1
  • Marie E. McDonnell
    • 1
    Email author
  1. 1.Section of Endocrinology, Diabetes, Nutrition and Weight ManagementBoston Medical CenterBostonUSA

Personalised recommendations